Researchers in the UK say Grail’s blood test for more than 50 different types of cancer has shown promise in a trial involving thousands of people with suspected cancer sy
Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this ye
The UK Life Sciences Council, a twice-yearly meeting between ministers and global life sciences industry leaders, met on Thursday 25th May to discuss the sector’s economic
Primary care doctors in the UK are a “negligible” provider of commercial clinical trial activity and should be incentivised to give experimental therapies to patients.
A new partnership between virtual ward start-up Doccla, wearable tech company AliveCor, and a UK healthcare trust will examine the care of patients with
The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-ex
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas